PHRX (Pharmagen) ROCE %: 0.00% (As of Mar. 2014)


What is Pharmagen ROCE %?

Pharmagen PHRX -90.00% ROCE % is 0.00% as of Mar. 2014.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pharmagen's annualized ROCE % for the quarter that ended in Mar. 2014 was 0.00%.

Pharmagen  (OTCPK:PHRX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pharmagen ROCE % Related Terms

Pharmagen ROCE % Historical Data

* Premium members only.

The historical data trend for Pharmagen's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen ROCE % Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
ROCE %
0.00 0.00 -1,324.09 0.00

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -344.51 0.00 0.00 0.00 0.00

Pharmagen ROCE % Calculation

Pharmagen's annualized ROCE % for the fiscal year that ended in Dec. 2013 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=-2.993/( ( (2.897 - 2.435) + (1.282 - 8.099) )/ 2 )
=-2.993/( (0.462+-6.817)/ 2 )
=-2.993/-3.1775
=94.19 %

Pharmagen's ROCE % of for the quarter that ended in Mar. 2014 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2014 )  (Q: Dec. 2013 )(Q: Mar. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2014 )  (Q: Dec. 2013 )(Q: Mar. 2014 )
=-0.272/( ( (1.282 - 8.099) + (1.28 - 8.295) )/ 2 )
=-0.272/( ( -6.817 + -7.015 )/ 2 )
=-0.272/-6.916
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2014) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Pharmagen (PHRX) has a ROCE % of 0.00% as of Mar. 2014.
Is Pharmagen's ROCE % too high?
Pharmagen's current ROCE % is 0.00%.
How does Pharmagen's ROCE % compare to FZMD and SNYR?
Pharmagen's ROCE % of 0.00% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmagen's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagen stock overvalued right now?
Pharmagen (PHRX) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Pharmagen (PHRX), the current ROCE % is 0.00% as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.